HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Current issues in the management of acute bacterial sinusitis in children.

AbstractOBJECTIVE:
To review and summarize recent challenges in the microbiology and treatment of acute bacterial sinusitis (ABS), one of the most common infectious diseases in the pediatric community.
METHODS:
A review of recent medical literature from 1990 to 2006 was acquired using the National Library of Medicine's PUBMED database.
RESULTS:
Multiple mechanisms of penicillin resistance have been identified: porin channel blockage, beta-lactamase production, and changes in penicillin-binding proteins (PBPs). Other factors affecting treatment efficacy include the role of normal nasopharyngeal flora, such as alpha-streptococci. The more widely documented shift in the causative pathogens of acute otitis media (AOM) following the release of the heptavalent pneumococcal conjugate vaccine (PCV7) has also been documented in two studies of ABS in children.
CONCLUSIONS:
Treatment of ABS in children is complicated by a number of emerging changes in pathogen resistance patterns. These include beta-lactamase-negative ampicillin resistance (BLNAR) and multi-drug resistance, bacterial interference, and geographic data. These phenomena are likely to impact the treatment of URIs. Appropriate diagnosis and differentiation from viral sinusitis is essential prior to initiating therapy. Clinician education about these emerging issues remains an important strategy in diagnosing and treating ABS in children. This includes an understanding of known patient adherence to antibiotic therapy, such as taste, tolerability, dosing schedule, therapy duration, and patient preference. Clinicians should review judicious ABS treatment approaches that employ agents with documented efficacy against implicated pathogens.
AuthorsItzhak Brook
JournalInternational journal of pediatric otorhinolaryngology (Int J Pediatr Otorhinolaryngol) Vol. 71 Issue 11 Pg. 1653-61 (Nov 2007) ISSN: 0165-5876 [Print] Ireland
PMID17629576 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Bacterial Agents
  • Pneumococcal Vaccines
Topics
  • Acute Disease
  • Anti-Bacterial Agents (therapeutic use)
  • Bacterial Infections (complications, epidemiology, prevention & control)
  • Child
  • Drug Administration Schedule
  • Drug Resistance, Microbial
  • Humans
  • Otitis Media (epidemiology, prevention & control)
  • Pneumococcal Vaccines (administration & dosage)
  • Sinusitis (epidemiology, microbiology, prevention & control)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: